Novel Software Systems and the Cancer Research Charitable Fund concluded a cooperation agreement.
Novel Software Systems and the Fund implement joint computational models for the effective determination of pathology using high-throughput RNA sequencing data (NGS RNASeq).
The model is based on autoencoders which is a special class of artificial neural networks. Neural network uses big data from various sources for training.
The Cancer Research Charitable Fund is a Russian non-profit organization, which creates and develops new technologies and innovative methods to fight cancer.
The main priorities of the Fund are:
1) search and development of breakthrough methods of research and effective treatment of oncology,
2) to conduct and support scientific and technical developments in the field of creating new, effective means and methods for the early diagnostics of cancer.